Close Menu

OpGen

BGI and OpGen believe that OpGen’s optical mapping technology will complement next-generation sequencing in order to "enable the efficient and accurate finishing of assembled contigs into chromosomes."

After a human genome collaboration, the US firm will continue its work with BGI to use optical mapping to finish de novo sequencing for more genome analysis projects.

The funding will support efforts to expand into new markets and develop applications that "will complement sequencing technologies and help facilitate rapid completion of large genome mapping and finishing technologies," according to CEO Douglas White.

OpGen will use the funds to support marketing of its recently launched Argus Optical Mapping System for automated, microbial whole-genome analysis.

New Products: Jun 15, 2010

Premium

NuGen's Encore NGS Library/Multiplex Systems and Ovation 3'-DGE System, OpGen's Argus Optical Mapping System

Pages

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.